During the past decade, University Medical Center, Inc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Medical Center, Inc" are "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Non Small Cell Lung Cancer (NSCLC)" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Squamous Cell Carcinoma of the Head and Neck" (1 trials). Many other conditions were trialed in "University Medical Center, Inc" in a lesser frequency.

Most popular intervention types in "University Medical Center, Inc" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Avelumab" (1 trials), "Chemoradiation" (1 trials), "Cyclophosphamide" (1 trials) and "Dacomitinib (PF-00299804)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center, Inc" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Medical Center, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University Medical Center, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center, Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".